2022
DOI: 10.1016/j.tracli.2021.12.006
|View full text |Cite
|
Sign up to set email alerts
|

SARS-CoV-2 variants in immunocompromised COVID-19 patients: The underlying causes and the way forward

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2
1

Citation Types

0
11
0
1

Year Published

2022
2022
2024
2024

Publication Types

Select...
5
1

Relationship

0
6

Authors

Journals

citations
Cited by 6 publications
(12 citation statements)
references
References 26 publications
0
11
0
1
Order By: Relevance
“…Even in the presence of VOC with mutations that alter vaccine efficacy, full vaccination is effective against severe COVID-19 caused by non-Omicron variants [ 192 ], resulting in a milder and shorter course of COVID-19, while booster doses have proven to improve neutralization against Omicron [ 175 ]. Furthermore, intra-host viral evolution during persistent infections leading to SARS-CoV-2 mutations identified in immune escape variants has been observed in immunocompromised patients [ 193 , 194 ]. In spring 2022, the mandatory use of face masks was repealed in Spain [ 195 ].…”
Section: Discussionmentioning
confidence: 99%
“…Even in the presence of VOC with mutations that alter vaccine efficacy, full vaccination is effective against severe COVID-19 caused by non-Omicron variants [ 192 ], resulting in a milder and shorter course of COVID-19, while booster doses have proven to improve neutralization against Omicron [ 175 ]. Furthermore, intra-host viral evolution during persistent infections leading to SARS-CoV-2 mutations identified in immune escape variants has been observed in immunocompromised patients [ 193 , 194 ]. In spring 2022, the mandatory use of face masks was repealed in Spain [ 195 ].…”
Section: Discussionmentioning
confidence: 99%
“…Finally, given reports that have suggested evolution of complexed populations of SARS-CoV-2 in immunocompromised people [44][45][46][47], we were interested to compare infections between IM+ and IM-individuals. While normalizing for overall complexity by comparing infections that occurred within time-similar cohorts, we did not observe increased numbers of iSNVs in IMpatients.…”
Section: Discussionmentioning
confidence: 99%
“…Finally, given published reports of extensive SARS-CoV-2 sequence diversity in association with infected immunocompromised (IM-) individuals [44][45][46][47], we have evaluated the complexity of SARS-CoV-2 sequence in the context of the immunological conditions of the infected individuals in our study. Because the infections studied included asymptomatic individuals and those who receive primary care outside the VA Northeast Ohio Healthcare System, it was not possible to conduct a complete association study on this focus.…”
Section: Association Between Immunological Competence and Sars-cov-2 ...mentioning
confidence: 99%
“…Finally, given published reports of extensive SARS-CoV-2 sequence diversity in association with infected immunocompromised (IM-) individuals [41][42][43][44], we have evaluated the complexity of SARS-CoV-2 sequence in the context of the immunological conditions of the infected individuals in our study. Because the infections studied included asymptomatic individuals and those who receive primary care outside the VA Northeast Ohio Healthcare System, it was not possible to conduct a complete association study on this focus and represents a limitation of our study.…”
Section: Association Between Immunological Competence and Sars-cov-2 ...mentioning
confidence: 99%
“…Finally, given reports that have suggested evolution of complexed populations of SARS-CoV-2 in immunocompromised people [41][42][43][44], we were interested to compare infections between IM+ and IM-individuals. While normalizing for overall complexity by comparing infections that occurred within time-similar cohorts, we did not observe increased numbers of iSNVs in IM-patients.…”
Section: Plos Geneticsmentioning
confidence: 99%